These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 20464796

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. On call. I am a 72-year-old man with gout. I was getting three or four painful attacks every year until my doctor put me on Zyloprim. The medicine has been great--I haven't had an attack in more than two years. But I developed a bad rash and had to give up my Zyloprim. What can I do now?
    Simon HB.
    Harv Mens Health Watch; 2004 Jun; 8(11):8. PubMed ID: 15210420
    [No Abstract] [Full Text] [Related]

  • 3. [How to select and use urate lowering agents for hyperuricemia].
    Yamanaka H.
    Nihon Rinsho; 1996 Dec; 54(12):3261-5. PubMed ID: 8976102
    [Abstract] [Full Text] [Related]

  • 4. [Hyperuricemia and gout--treatment].
    Gröbner W, Walter-Sack I.
    Dtsch Med Wochenschr; 2002 Feb 01; 127(5):210-3. PubMed ID: 11821994
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout.
    Reinders MK, Haagsma C, Jansen TL, van Roon EN, Delsing J, van de Laar MA, Brouwers JR.
    Ann Rheum Dis; 2009 Jun 01; 68(6):892-7. PubMed ID: 18633127
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol.
    Reinders MK, van Roon EN, Jansen TL, Delsing J, Griep EN, Hoekstra M, van de Laar MA, Brouwers JR.
    Ann Rheum Dis; 2009 Jan 01; 68(1):51-6. PubMed ID: 18250112
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Opportunities for improving medication use and monitoring in gout.
    Singh JA, Hodges JS, Asch SM.
    Ann Rheum Dis; 2009 Aug 01; 68(8):1265-70. PubMed ID: 18701554
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Febuxostat: new drug. Hyperuricaemia: risk of gout attacks.
    Prescrire Int; 2009 Apr 01; 18(100):63-5. PubMed ID: 19585722
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. On call. I was recently diagnosed with gout. I'm feeling well with medication, but my doctor want me to take drugs for my cholesterol and blood pressure because gout will raise my risk of heart attack. I don't want to take more pills. What do you think?
    Simon HB.
    Harv Mens Health Watch; 2004 May 01; 8(10):8. PubMed ID: 15153389
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Successful desensitisation of allopurinol-induced erythema multiforme.
    Fonseka MM, Sathischandra H, Jayamanne SF, de Silva HJ.
    Ceylon Med J; 1999 Dec 01; 44(4):190-1. PubMed ID: 10895280
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.